Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1623 1637 1656 1673 1693 3762
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18674521 | ENZYMATIC SYNTHESIS OF HOMOGENEOUS CHONDROITIN SULFATE OLIGOSACCHARIDES | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Final Rejection | The Regents of the University of California |
| 18017306 | METHOD FOR MODULATING THE BLADDER MICROBIOME TO IMPROVE BLADDER HEALTH | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18687785 | CONJUGATES, COMPOSITIONS, AND METHODS FOR REJUVENATION OF CAR T-CELLS | Non-Final OA | Purdue Research Foundation |
| 18449862 | PROCESS FOR THE DE-TRITYLATION OF OLIGONUCLEOTIDES | Final Rejection | Hoffmann-La Roche Inc. |
| 18410094 | METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION | Non-Final OA | ASTRAZENECA AB |
| 18839102 | Compounds for Anti-aging Intervention | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 18627191 | COMPOUNDS FOR TREATING OR PREVENTING ALZHEIMER'S DISEASE | Non-Final OA | THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human |
| 17755634 | CELLULOSE ESTERS COMPRISING RECYCLE CONTENT BUTYRYL | Non-Final OA | ExxonMobil Product Solutions Company |
| 18713342 | FLAVANOID CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS | Non-Final OA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 17999400 | MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE X ASSOCIATED DISORDERS | Final Rejection | SERVIER PHARMACEUTICALS LLC |
| 16980207 | METHOD OF TREATMENT | Final Rejection | NUCHIDO LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy